Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects.

Source:http://linkedlifedata.com/resource/pubmed/id/15002017

Download in:

View as

General Info

PMID
15002017